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Ocular infection by HSV-1 strain McKrae is neurovirulent in both mice and rabbits and causes fatal
encephalitis in approximately 50% of animals. In addition, it spontaneously reactivates with high
frequency relative to other HSV-1 strains in rabbits. We sequenced the McKrae strain genome and
compared its coding protein sequences with those of six other HSV-1 strains. Most of the 74 predicted
protein sequences are conserved; only eleven are less than 98% conserved. Eight proteins were
identiﬁed to be unique for McKrae based on sequence homology bit score ratio (BSR). These include ﬁve
proteins showing signiﬁcant variations (RL1, RS1, UL49A, US7 and US11), two truncated proteins (UL36
and UL56) and one (US10) containing an extended open reading frame. The McKrae strain also has
unique features in its ‘a’ sequence and non-coding sequences, such as LAT and miRNA. These data are
indicative of strain variation but need further work to connect observed differences with phenotype
effects.
& 2012 Elsevier Inc. All rights reserved.Introduction
Herpes simplex virus type 1 (HSV-1) is a widespread human
pathogen that establishes a lifelong infection characterized by
recurrent cycles of latency and reactivation. To date, there are 17
strains of HSV-1 that have been isolated (ICTV 2011 taxonomy).
Among them, 7 genomes have been completed or partly com-
pleted. The reference strain 17 (NC_001806, X14112) is often used
for genome sequence comparison. HSV-1 has a large double
stranded DNA genome of approximately 150 kb that is composed
of a unique long (UL) region (106.5 kb), a unique short (US) region
(13.5 kb), two copies of a long inverted repeat (RL) (8.75 kb each),
and two copies of a short inverted repeat (RS) (6.25 kb each).
During primary infection, HSV-1 undergoes productive repli-
cation in epithelial cells typically of the oral, nasal, or ocular
mucosa. HSV-1 virions eventually infect the trigeminal ganglia by
entering nerve endings at the site of infection, and a life-long
latent infection is established in a subset of neurons (Hill et al.,ll rights reserved.
edical Sciences, College of
Corvallis, OR 97331, USA.1996). The HSV-1 genome is largely inactive during latency,
except for expression of the latency associated transcript (LAT)
(Rock et al., 1987; Stevens et al., 1987). HSV-1 latency may
reactivate spontaneously or in response to stress resulting in
production of infectious viruses/particles. Infectious particles are
transported to peripheral sites where lytic replication ensues.
Investigations into HSV-1 reactivation have implicated several
viral gene products and genome regions including RS1 (ICP4; a
major transcriptional activator/repressor), RL1 (ICP34.5; a neuro-
virulence factor), RL2 (ICP0; a transcription regulator and ubiqui-
tin ligase), and LAT (Halford et al., 2001; Halford and Schaffer,
2001; Perng et al., 1994). Ectopic expression of RS1 (ICP4) or RL2
(ICP0) induces viral replication from a quiescent state in vitro, and
deletions in the LAT promoter or LAT transcript have been shown
to severely diminish reactivation in vivo (Block et al., 1993;
Halford et al., 2001; Halford and Schaffer, 2001; Hill et al.,
1990; Leib et al., 1989; Perng et al., 1994, 1996, 1999). These
genes all map to the inverted repeat regions of the viral genome.
In addition, both micro-RNAs (Umbach et al., 2008) and apoptosis
have been implicated in latency reactivation (Jin et al., 2005;
Perng et al., 2000). Although several factors inﬂuencing reactiva-
tion from latency have been identiﬁed, the study of HSV-1
reactivation is complicated by the fact that reactivation frequency
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(Hill et al., 1987). For example, in the rabbit model, HSV-1 strains
McKrae, 17, and KOS each have a distinct reactivation phenotype
(high, medium, and low frequency, respectively) (Hill et al., 1987;
Perng et al., 2002).
In addition, HSV-1 strains show variation in virulence and
pathogenesis (Perng et al., 2002; Stroop and Schaefer, 1987).
Among laboratory strains (McKrae, 17, KOS, F, and H129), McKrae
is relatively virulent and neuroinvasive in mice and rabbits,
resulting in 50% mortality at 2105 pfu per eye in animals
infected by the ocular route without corneal scariﬁcation (Jin
et al., 2007, 2005), whereas strains 17 and KOS infect the rabbit
eye poorly without corneal scariﬁcation (Hill et al., 1987; Perng
et al., 2002). RL1 (ICP34.5) is a neurovirulence factor, and the
McKrae strain variant has been shown to confer the virulent
phenotype in recombinants (Bower et al., 1999; Mao, 2002; Mao
and Rosenthal, 2003; Perng et al., 2002). In this report we describe
the use of high throughput sequencing to determine the HSV-1
McKrae genome sequence and employ comparative genomic
analysis using the previously sequenced HSV-1 genomes from
strains F, H129, 17, HF10, and KOS sequences to locate protein
and genomic sequence variability between strains that may
contribute to the neurovirulence and high frequency reactivation
associated with the McKrae strain.Results and discussion
The McKrae genome sequence
The HSV-1 genome has an architecture composed of a unique
long (UL) element, a unique short (US) element, and two distinct
inverted repeat elements which ﬂank the UL and US termed the
repeat long (RL) and repeat short (RS) (Fig. 1). A total of 243,155
sequence reads were generated from 454 GS FLXþ system with the
sequence length ranging from 40 bp to 1209 bp with mean sequence
length at 339 bp and mode read length at 429 bp. The N50 contig
size is 22,626 bp. More than 99% of the sequences have an average
base Phred quality score of greater than 20 (Supplemental Fig. 1). The
total bases are 82,442,028 with the genome coverage of 589.6X.
From 243,155 sequence reads, the initial de novo assembling using
the Newbler software generated nine large contig homologous to the
UL, US, RL, and RS of the strain 17 genome (Fig. 1C). There are 12,808
sequence singlets that were not assembled and may be the host
source sequences or low quality sequences. PCR sequencing wasLURL
C1
UL6 UL17 UL30
UL36
RS1RL1
Fig. 1. Construction of the McKrae genome. All sequence contigs and primer sequenced
The unique long (UL) and unique short (US) regions are ﬂanked by distinct inverted re
novo assembled contigs (C1–C9) from 454 Sequencing and their approximate location d
the assembly. PCR-sequencing was used to bridge the contigs. D: Gene coding regions cused to conﬁrm contigs and gaps. The de novo assembled contigs
were 134,004 bp in total length. Excluding one copy of each repeat
element, the strain 17 reference genome (Accession no. X14112) is
approximately 136,500 bp, indicating that the initial contigs covered
nearly the entire genome. Contigs were ordered by alignment to the
strain 17 genome. The McKrae genome was assembled in such a
manner as to create one continuous contig beginning with viral gene
UL1 at the left end and viral gene US12 at the right end. Terminal
repeat elements were added after the above sequence was deter-
mined by inverting the respective long and short internal repeat
sequences and appending them to the draft sequence ends. This
resulted in a ﬁnal sequence of 151,135 bp. Omitting tandem repeats
present at the UL—internal repeat long (IRL) and US—internal repeat
short (IRS) junctions, the HSV-1 McKrae genome regions are UL
107,759 bp, US 13,514 bp, IRL 8,720 bp, and IRS 6,200 bp. The length
of internal repeats reported here include the viral ‘a’ sequence.
The genome contains all 77 open reading frames (ORFs) known to
encode proteins in the HSV-1 genome (this includes repeated coding
sequences in the inverted repeat elements), as well as two ORFs
corresponding to ORF-O and ORF-P in the long inverted repeat. ORFs
shared by McKrae and strain 17 show synteny across the entire
genome.
The HSV-1 genome is GC rich and contains many repeat elements,
which can cause complications when attempting to assemble a
genome de novo. The Roche 454 sequencing platform was speciﬁcally
chosen because it generates relatively long reads that we hoped to
span tandem repeat elements. One drawback, however, is its inability
to resolve mononucleotide repeats past seven or eight residues due to
detection saturation. Several regions in the McKrae genome contain
long mononucleotide repeats, and in an alignment to strain 17 we
noted deletions in strain McKrae mononucleotide runs. It is unclear
whether these deletions represent real variation or natural ﬂuctua-
tions in repeat size, or are simply sequence regions where saturation
was reached. Discrepancies within coding regions were conﬁrmed by
PCR product sequencing to ensure accurate predicted protein
sequences for comparative analysis. High throughput sequencing also
had difﬁculty sequencing particular genome regions [speciﬁcally oriL
and RS1 (ICP4)]. However, this same deﬁciency was seen using the
standard Sanger methods, suggesting the underlying sequence was
responsible for the difﬁculties as opposed to the sequencing method.
Sequence comparison of predicted proteins
Predicted protein sequences from HSV-1 strains McKrae, 17, F,
H129, HF10, and KOS were aligned for comparative analysis usingSRSUSRRL
          C3  C5      C7        C9
C2 C4  C6           C8
UL47
UL43UL37
US04 US07 US10 US11US08
UL56
regions are aligned vertically. A: Scale of HSV-1 genome. B: HSV-1 genome regions.
peats termed the repeat long (RL) and repeat short (RS), respectively. C: Initial de
etermined by alignment to HSV-1 strain 17. Staggering of contigs indicates a gap in
onﬁrmed by PCR sequencing and their location (triangles) in the McKrae genome.
Table 1
Conservation of genes between HSV-1 strains: 17, McKrae, F strain, H129, HF10,
and two KOS.
Name aPairwise
identity (%)
No. ofb
sequences
Max.
sequence
length
Min.
sequence
length
Sequence
length
RL1 95.00 7 257 240 258
RL2 98.10 7 777 768 783
RS1 98.30 7 1303 1294 1304
UL1 97.30 7 224 224 224
UL2 97.70 7 334 334 334
UL3 99.70 7 235 235 235
UL4 99.00 7 199 198 199
UL5 99.50 7 882 882 882
UL6 99.40 7 676 676 676
UL7 99.60 7 296 296 296
UL8 99.20 7 750 750 750
UL9 97.80 7 851 793 851
UL10 99.30 7 473 473 473
UL11 97.60 7 96 96 96
UL12 99.40 7 626 626 626
UL13 99.00 7 518 518 518
UL14 98.50 7 219 219 219
UL15 99.90 7 735 735 735
UL16 99.90 7 373 373 373
UL17 99.10 7 703 702 703
UL18 99.70 7 318 318 318
UL19 99.60 7 1374 1374 1374
UL20 99.70 7 222 222 222
UL21 99.80 7 535 535 535
UL22 99.50 7 838 838 838
UL23 99.10 7 376 376 376
UL24 99.10 7 269 269 269
UL25 99.80 7 580 580 580
UL26 99.40 7 635 635 635
UL26.5 99.30 6 329 329 329
UL27 99.10 7 904 904 904
UL28 99.90 7 785 785 785
UL29 99.70 7 1196 1196 1196
UL30 99.50 7 1235 1235 1235
UL31 99.70 7 306 306 306
UL32 99.60 7 596 595 596
UL33 99.80 7 130 130 130
UL34 99.70 7 275 275 275
UL35 100.00 7 112 112 112
UL36 96.40 7 3164 2775 3169
UL37 99.50 7 1123 1123 1123
UL38 99.70 7 465 465 465
UL39 99.60 7 1137 1137 1137
UL40 99.40 6 340 340 340
UL41 99.50 7 489 489 489
UL42 99.20 7 488 488 488
UL43 96.90 6 434 357 434
UL44 98.60 7 511 511 511
UL45 100.00 6 172 172 172
UL46 98.60 7 719 717 719
UL47 99.80 7 693 693 693
UL48 99.40 7 490 489 490
UL49 98.80 7 301 301 301
UL49A 99.00 6 91 91 91
UL50 99.10 7 371 370 371
UL51 99.30 7 244 244 244
UL52 99.70 7 1058 1056 1058
UL53 99.60 7 338 338 338
UL54 99.40 7 512 512 512
UL55 99.60 6 186 186 186
UL56 88.70 6 234 180 237
US1 98.70 7 420 420 420
US2 98.80 7 291 291 291
US3 99.30 7 481 481 481
US4 96.80 7 239 238 239
US5 99.50 7 92 92 92
US6 99.40 7 394 394 394
US7 95.30 7 418 383 418
US8 99.20 7 552 550 552
US8A 98.80 7 190 159 190
US9 99.30 7 90 57 90
US10 92.30 7 507 300 516
Table 1 (continued )
Name aPairwise
identity (%)
No. ofb
sequences
Max.
sequence
length
Min.
sequence
length
Sequence
length
US11 95.30 7 161 149 161
US12 98.50 7 88 88 88
a Percentage of amino acid identity.
b Number of strains; 7¼all strains; 6¼all stains but HF10.
G. Watson et al. / Virology 433 (2012) 528–537530the Geneious Software. Fully sequenced and annotated HSV-1
genome data is available for F strain (Accession no. GU734771),
H129 (Accession no. GU734772), and strain 17 (Accession no.
X14112). The strain HF10 (Accession no. DQ889502) sequence is
not complete, but most coding regions are annotated. We included
strain HF10 predicted protein sequences in our analysis, but
omitted any non-coding comparisons due to missing sequence
data and an uncharacterized reactivation phenotype. In addition,
two fully sequenced and annotated KOS genomes (Accession no.
JQ780693 and JQ673480) were published recently. Both of them
were included in our analysis.
The pairwise percent identity was calculated in multiple
alignments for each protein. Of the 74 unique predicted protein
sequences found in HSV-1, 63 proteins are Z98% conserved
between strains, whereas 11 proteins are less than 98% conserved
(Table 1). In an earlier comparative analysis of three HSV-1 strains
(17, F, and H129), ten protein sequences were found to be
completely conserved (Szpara et al., 2010). The addition of three
strains (McKrae and KOS) in these analyses revealed only four
proteins (UL16, UL20, UL35, and UL45) to be conserved between
strains, and only two proteins (UL35 and UL45) were found to be
completely conserved when HF10 was included and all seven
strain sequences were compared (Tables 1 and 2). Not all of these
perfectly conserved proteins are necessary for viral growth in
culture, and it has been suggested that maintenance of coding
sequence in these proteins is the result of selection and enhanced
ﬁtness (Szpara et al., 2010). The addition of McKrae, HF10, and
KOS coding sequences has narrowed the focus of this list and has
provided more evidence for an evolutionary advantage associated
with sequence conservation in these proteins.Identiﬁcation of protein variants
The goal of this comparative analysis was to identify protein or
sequence features unique to strain McKrae that might contribute
to its characteristic pathogenesis and high frequency of sponta-
neous reactivation. We searched the homology of each protein of
McKrae against six other strains by BLAST tool (blast.ncbi.nlm.-
nih.gov) and calculated the sequence homology bit score (BS).
A bit score matrix was generated by searching each protein of
McKrae against that of six other strains as well as that of McKrae
itself (Supplemental Table 1). The homology bit score ratio (BSR)
was the ratio between the average BS of each other strains against
McKrae BS and the BS of McKrae against McKrae. BSR value then
is a representation of how different (substitutions and indels) a
McKrae protein is from a relevant protein of other strains. If there
is no difference, the BSR will be 1; however, the BSR will be lower
than 1 if there are variations between McKrae and other strains.
Using this approach, we were able to generate a list of proteins
containing variation comparing to those from McKrae (Table 2).
Proteins UL56, RL1 (ICP34.5), US10, RS1 (ICP4), US11, US07
(glycoprotein I; gI), UL36 and UL49A are found to contain a
Table 2 (continued )
McKrae No. of other BSRa No. of other BSRb
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proteins that were previously identiﬁed to be associated with
pathogenesis and latency reactivations, speciﬁcally RL1 and RS1.Table 2
Protein variants from McKrae sorted by bit score ratio (BSR).
McKrae No. of other
strains
BSRa No. of other
strains
BSRb
UL56 5 0.353 5 0.353
RL1 5 0.387 6 0.387
US10 5 0.479 6 0.479
RS1 5 0.669 6 0.669
US11 5 0.719 6 0.705
US7 5 0.787 6 0.784
UL49A 5 0.790 5 0.790
RL2 5 0.810 6 0.803
UL36 5 0.829 6 0.830
US9 5 0.852 6 0.875
UL43 5 0.885 5 0.885
US4 5 0.902 6 0.892
UL46 5 0.909 6 0.920
US8 5 0.920 6 0.916
UL1 5 0.925 6 0.938
UL40 5 0.935 6 0.944
UL2 5 0.955 6 0.963
UL17 5 0.964 6 0.968
UL9 5 0.976 6 0.979
UL11 5 0.979 6 0.980
UL4 5 0.980 6 0.980
UL32 5 0.981 6 0.972
UL50 5 0.982 6 0.984
UL55 5 0.985 5 0.985
UL14 5 0.987 6 0.975
UL42 5 0.987 6 0.987
UL23 5 0.988 6 0.986
US12 5 0.988 6 0.985
UL44 5 0.988 6 0.979
US3 5 0.989 6 0.990
UL6 5 0.990 6 0.990
US1 5 0.990 6 0.991
UL49 5 0.990 6 0.990
UL27 5 0.991 6 0.991
US2 5 0.991 6 0.991
UL37 5 0.992 6 0.992
UL13 5 0.992 6 0.991
UL8 5 0.993 6 0.992
UL12 5 0.993 6 0.993
UL26 5 0.993 6 0.993
UL51 5 0.993 6 0.994
UL48 5 0.994 6 0.994
UL38 5 0.994 6 0.995
UL5 5 0.994 6 0.995
UL7 5 0.994 6 0.994
UL24 5 0.994 6 0.994
UL52 5 0.994 6 0.995
UL10 5 0.995 6 0.994
UL26.5 5 0.995 5 0.995
UL30 5 0.996 6 0.995
US5 5 0.996 6 0.996
UL54 5 0.996 6 0.996
UL39 5 0.996 6 0.997
UL31 5 0.996 6 0.997
UL22 5 0.996 6 0.996
UL34 5 0.997 6 0.997
US8A 5 0.997 6 0.994
US6 5 0.997 6 0.997
UL41 5 0.997 6 0.997
UL29 5 0.997 6 0.997
UL3 5 0.998 6 0.998
UL53 5 0.998 6 0.997
UL47 5 0.998 6 0.998
UL19 5 0.998 6 0.998
UL33 5 0.998 6 0.999
UL18 5 0.999 6 0.998
UL21 5 0.999 6 0.998
UL25 5 0.999 6 0.999
strains strains
UL15 5 0.999 6 0.999
UL28 5 0.999 6 0.999
UL16 5 1.000 6 0.999
UL20 5 1.000 6 0.999
UL35 5 1.000 6 1.000
UL45 5 1.000 6 1.000
a The BS mean of KOS (JQ673480), KOS (JQ780693), F(GU734771),
H129(GU734772), and 17 (X14112), was divided by the BS of McKrae (JQ730035).
b The BS mean of KOS (JQ673480), KOS (JQ780693), F(GU734771),
H129(GU734772), 17(X14112), and HF10 (DQ889502), was divided by the BS of
McKrae (JQ730035). When a protein is not available from HF10, the numerator is
the mean of ﬁve proteins available. The BS is generated by blast search against
McKrae protein sequence using each relevant sequence of each strain including
McKrae itself.Protein variants
The identiﬁcation of RL1 (ICP34.5) using the BSR method
indicates that it is capable of identifying protein variants that
have been linked to a speciﬁc phenotype (Mao, 2002; Perng et al.,
2002). The ICP34.5 protein of HSV-1 is a neurovirulence factor
that play critical roles in viral replication and anti-host responses
(Bolovan et al., 1994; Li et al., 2011). Strain McKrae RL1 (ICP34.5)
has a lower BSR (0.387) due to an extended P–A–T repeat
between residues 159 and 160 that results in 8 iterations while
other strains contain only 3–5 iterations. This extended repeat has
been shown experimentally to control cellular localization of the
RL1 (ICP34.5) protein, while a chimeric virus suggests this region
is important for virulence phenotype when integrated into a non-
virulent HSV-1 strain (Mao, 2002; Perng et al., 2002).
The RS1 (ICP4) of McKrae has been previously identiﬁed to be
important for latency reactivation in vivo (Halford et al., 2001).
RS1 is an immediate early transcriptional regulator and recog-
nizes DNA motifs in several immediate early genes as well as in
the LAT promoter (Kuddus et al., 1995; Shepard et al., 1989). The
coding sequence contains a block of variation in an alanine rich
region (AASAPDAADALAAA) between residues 707 and 720,
which are present in the other six strains but not in McKrae
(Fig. 2), where the alanine rich region is replaced by a serine rich
sequence (GPRRSSSSSGVAA-) (Fig. 2). The serine rich block of
substitutions present in McKrae is adjacent to the nuclear
localization signal (NLS) (amino acid 728–734). A change in
conformation of this region may alter the NLS and in turn affect
localization of not only ICP4, but also other viral proteins (e.g.
ICP0, ICP8) that are affected by ICP4 localization (Knipe and
Smith, 1986). The fact that ICP4 is an immediate early transcrip-
tional regulator and has been implicated in reactivation suggests
that this variation may inﬂuence phenotype.
The low BSR for US07 (gI) (0.78) is also the result of an extended
repeat element located within the coding sequence. Strain McKrae
contains six perfect iterations of the internal tandem repeat
STPSTTT. The STPSTTT repeat resides in the predicted extravirion
domain of the US07 (gI) protein (UniProt Identiﬁer: P06487). US07
(gI) interacts with host immunoglobulin G (IgG) through hetero-
dimerization with US08 (gE), and alterations in the extravirion
domain could affect recognition of either proteins (Johnson et al.,
1988). In a report investigating HSV-1 phylogeny, gI sequences
were used to look at diversity of HSV-1 isolates, and therefore a
large number of gI sequences are available (Norberg et al., 2004).
An alignment of forty-seven gI protein sequences showed con-
siderable diversity in the number and composition of the STPSTTT
repeat element (Fig. 3). Only one isolate (lcl931811) contained the
Fig. 2. Variation in the HSV-1 RS1 (ICP4) sequence. A: Schematic structure of RS1 (ICP4) protein with functional domains. NLS: nuclear localization signal. B: Multiple
sequence alignment within the expanded region near NLS between AA 686-739. The McKrae unique substitution is noted. Multiple sequence alignment and the expanded
regions were produced using the Geneious Software.
Extravirion Domain Intravirion DomainTM
Fig. 3. HSV-1 US07. A: Diagram of US07 (gI) extravirion and intravirion domains separated by the transmembrane (TM) domain. B: Alignment of the US07 (gI) STPSTTT
tandem repeat from 47 protein sequences. Tandem repeats are sorted by increasing number of perfect repeats. Strain McKrae and isolate lcl931811 contain the largest
number of perfect repeats. Graphic from Geneious Software.
G. Watson et al. / Virology 433 (2012) 528–537532six perfect iterations found in strain McKrae, suggesting this large
iteration number is relatively rare. HSV-1 glycoproteins are known
to interact with host cell membrane proteins and mediate envelope
fusion and viral entry (Browne et al., 2001; Turner et al., 1998).
Disruption of the US07 (gI) gene results in attenuation in vivo and
a compromised spread-phenotype in vitro, which effectively
suggests US07 (gI) contributes to the virus pathogenicity (Balan
et al., 1994). It is tempting to speculate that the McKrae strain
US07 variant may facilitate an increased cell-to-cell spread and
pathogenesis.
Proteins predicted to contain large truncations (UL36, UL43,
UL56) or extended ORFs (US10) were also found to have lower
BSR (o0.85). McKrae UL36, the large tegument protein, contains
a premature stop codon introduced due to a G nucleotide deletion
in a mononucleotide string encoding amino acid residue 2453
(nt 72,535). As a consequence, UL36 encodes a unique and relatively
short C-terminus of 321 amino acids relative to the mutation site as
opposed to over 700 residues in the compared strains. The premature
stop codon causes a loss of the 70-amino acid PQ repeat. It has been
reported that residues 2430–2893 of wild type HSV-1 UL36 containsa binding site for the capsid protein UL25 (pUL25), which is required
to recruit protein encoded by UL36 (pUL36) onto cytosolic capsids
during assembly for secondary envelopment. In addition, the 167
residues of the very C terminus contain a second pUL25 binding site
crucial to maintain pUL36 on incoming capsids during cell entry
(Schipke et al., 2012). This suggests that McKrae pUL36 may have an
altered interaction with pUL25. At a minimum, partial UL36 function
is intact as McKrae does not have a UL36 null phenotype which
would be characterized by a cytoplasmic build-up of unenveloped
viral capsids (Desai, 2000).
McKrae strain gene UL56 (180 aa) contains a single base pair
insertion at nucleotide 115,992 (amino acid 97). This results in a
divergent and truncated C-terminus of only 83 aa (compared to
137 aa in other strains), which signiﬁcantly reduced the BSR of
UL56. UL56 has been implicated in pathogenicity (Kehm et al.,
1996); restoring UL56 expression in the non-expressing, avirulent
HSV-1 strain HFEM resulted in a pathogenic phenotype. In addition,
C-terminal deletions in UL56 lead to a much reduced pathogenicity.
The predicted C-terminal loss in the McKrae strain does not seem to
agree with these previous studies. The authors acknowledge their
557 bp
409 bp
L           A         B        A          B
17      McKrae
Fig. 4. oriL PCR ampliﬁcation products. The oriL hairpin was ampliﬁed only in the
presence of PCR Enhancer (Invitrogen). Lane A: oriL PCR supplemented with
enhancer to 1X concentration. Lane B: oriL PCR supplemented with enhancer to 2X
concentration. The 409 bp band in lane A is an amplicon of the oriL site in a stable
hairpin. The 557 bp band in lane B is the relaxed oriL PCR product. L: 1 kb Plus
DNA Ladder (Invitrogen). Template is genomic DNA.
G. Watson et al. / Virology 433 (2012) 528–537 533observations may be speciﬁc to the infection route (intraperitoneally,
IP); however, strain McKrae is pathogenic in mice by IP infection
(Kehm et al., 1996; Weir et al., 1989). The presence of the UL56
mutation in the virulent McKrae strain may reﬂect phenotypic
masking by a dominant protein variant in strain McKrae, possibly
RL1 (ICP34.5) or US07 (gI).
US10 extended ORF is the result of a single bp insertion at
nucleotide 143,416. The frameshift causes a stop codon loss in
McKrae and a unique C-terminal protein sequence. Strain McKrae
US10 is therefore predicted to be 317 amino acids long—ﬁve to
seventeen residues longer than the compared strains (Table 1).
The maximum length of US10 is the predicted sequence length for
strain McKrae US10 from start codon to the ﬁrst encountered stop
codon. The revised length above takes into account an intact US10
transcription termination sequence (Rixon and McGeoch, 1984).
The transcriptional machinery should terminate as usual, giving
rise to a US10 transcript containing no translational stop codon.
US10 is a capsid/tegument protein and localizes to the nucleus
during infection (Yamada et al., 1997). It has not been fully
characterized, and the effects of a predicted extended ORF are
unknown.
UL49A (glycoprotein N) of strain McKrae was also found to
have a lower BSR when compared to the other six strains. UL49A
has two aa differences at residues 28 and 51 with histidine and
threonine for McKrae, arginine and threonine for 17, and histidine
and alanine for the other strains. Among all the strains, UL49A
was also found to contain variability unique to F strain (Szpara
et al., 2010). No UL49A was annotated in HF10 strain; therefore,
BSR is not calculated when HF10 strain was included in the
comparison. US11 is an RNA binding protein involved in transla-
tion regulation. This analysis also ﬁnds that US11 is unique
for McKrae and H129 with 6, 9, and 12 aa deletion near the
c-terminal when compared to HF10, 17, and KOS strains, respec-
tively (Sup Fig. 2A).
Non-coding sequence variation: origin of replication L (oriL)
The initial strain McKrae genome assembly did not appear to
contain an oriL site. Standard PCR ampliﬁcation of the region,
followed by amplicon sequencing, conﬁrmed this result. Although
oriL is not required for genome replication and establishment of
latency, previous research has associated oriL with enhanced
neuronal replication in vitro and efﬁcient reactivation in vivo
(Balliet and Schaffer, 2006; Polvino-Bodnar et al., 1987). oriL also
contains neuron speciﬁc protein binding sites, suggesting an
important role for replication during active infection and adapta-
tion to respond to neuronal signals during reactivation (Hardwicke
and Schaffer, 1997). The presence of oriS in the initial assembly led
to the conclusion that 454 sequencing is capable of sequencing
through the hairpin structures formed by the replication origins. To
further examine the McKrae strain oriL deletion, the same region in
strain 17 was ampliﬁed. However, it also produced a PCR product
reﬂecting an oriL deletion (Fig. 4). As shown in Fig. 4, the 409 bp
band in lane A is an amplicon of the oriL site in a stable hairpin.
PCR sequencing of this product indicated an oriL deletion. The
557 bp product in lane B is the relaxed oriL site and indicates the
presence of oriL. Sequencing of the relaxed hairpin PCR product
produced sequence ends that conﬁrmed the product was from the
oriL site. We were, however, unable to sequence through the entire
hairpin using either standard or modiﬁed Sanger sequencing
protocols. Although we were unable to sequence a 102 bp region
(strain 17 bp 62,416–62,517) encompassing the apex of the oriL
hairpin, our data is consistent with the presence of oriL, and it is
reasonable to conclude that the McKrae oriL does not signiﬁcantly
differ from replication origins present in the compared strains,
which are 100% conserved.Inverted repeats
The inverted repeat consists of the long and short inverted (or
internal) repeats (Fig. 5A). An inverted copy of each repeat, of
course, also ﬂanks the opposite end of the unique long and unique
short regions, respectively. The inverted repeats surrounding UL
and US are of particular interest because they are the only
signiﬁcantly active sites of the viral genome during latency, and
emergence from the latent state is affected by proteins and other
genome features in this region (Fig. 5) (Block et al., 1993; Halford
et al., 2001; Halford and Schaffer, 2001; Hill et al., 1990; Leib
et al., 1989; Perng et al., 1996; Perng et al., 1995; Stevens et al.,
1987). The inverted repeats contain the viral protein coding
sequences for RL1 (ICP34.5), RL2 (ICP0), and RS1 (ICP4), the
non-coding latency associated transcript (LAT), open reading
frames ORF-O and ORF-P, the ‘a’ sequence, oriS, several tandem
repeat elements, and several micro-RNAs (miRNAs) (Fig. 5A).
Tandem repeats found at the UL–RL junction are related but
distinct, and they are reduced in strain McKrae (49 bp in McKrae
as opposed to 181 bp in strain 17 and KOS). Immediately
following the UL–RL junction repeat, strain McKrae is missing a
signiﬁcant amount of sequence compared to other strains
(approximately 330 nt). The RS–US junction is nearly identical
between strains, and the oriS sequence just upstream is perfectly
conserved.
The ‘a’ sequence
HSV-1 McKrae strain has a unique ‘a’ sequence compared to
the other well-deﬁned lab strains included in these analyses
(Fig. 5B). The HSV-1 ‘a’ sequence is present at the internal RL–RS
junction and at the ends of the linear genome. Variability in the
Fig. 5. Internal repeat (IR) region multiple sequence alignment and HSV-1 ‘a’ sequence. A: alignment of six sequences covering the internal repeat (IR) region: McKrae
strain, F strain, H129, strain 17, KOS promoter sequence, and KOS sequence covering the LAT intron. The histogram above the alignment represents percent identity
between strains using a sliding window of 99 base pairs; dark green indicates 100% identity; red indicates below 30% identity. Gaps between the black boxes in the
alignment of 5 strains shown correspond to gaps in the alignment. Annotations below the multiple sequence alignment are relative to strain McKrae and cover regions of
interest in these analyses. RL: Repeat Long; UL: Unique Long; RS: Repeat Short; US: Unique Short; SI: StyI region; dLAT2903: 5’ LAT transcript region; LP: LAT Promoter;
oriS: origin of replication S; RL2: ICP0; RL1: ICP34.5; RS1: ICP4: ‘a’: ‘a’ sequence. Base numbers are relative to strain McKrae. B: subunit structure of the HSV-1 ‘a’ sequence
and the composition of the DR2 array by strain. Strain McKrae contains two identical guanine rich insertions (McKrae nt 125,114 and nt 125,170). DR1: direct repeat 1 (19–
20 bp); Ub: unique sequence (65–77 bp); DR2 array: direct repeat 2 array (108–235 bp); DR4; direct repeat 4 (19–20 bp); Uc: unique sequence (58 bp). The y-axis is the
scale of sequence alignment identity. Image produced using the Geneious Software.
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isolates, but the subunit pattern is conserved (Umene, 2001;
Umene et al., 2008). The McKrae sequence contains unique varia-
tion within the ‘a’ sequence direct repeat 2 (DR2) array. Instead of
consisting of a series of unbroken tandem repeats, the McKrae DR2
repeats are interrupted twice by identical guanine-rich sequences.
The viral ‘a’ sequence has been implicated in genome stability and
recombination rate (Umene, 1991, 1993). The effect of interrupting
the DR2 repeat with divergent sequence strings may have an effect
on recombination, but could also affect RL1 (ICP34.5) expression
(Chou and Roizman, 1986; Martin and Weber, 1998). Upstream
promoter elements inﬂuencing RL1 (ICP34.5) expression have been
found in the DR2 array and have been shown to alter expression
in vitro. Differences in repeat length, especially in the DR2 array,
are present between strains, but this may not be as signiﬁcant as
the structural variation described here for strain McKrae.
The LAT region
Previous work has shown HSV-1 LAT to be required for
spontaneous reactivation, and we hypothesized that a multiple
sequence alignment of the LAT region would identify sequence
features unique to strain McKrae (Fig. 5A). In these analyses, the
full LAT transcript was inferred from existing McKrae sequence
data, annotations, and sequence markers present in the compared
strains. The LAT TATA promoter sequence is 27 nt upstream of the
proposed transcription start site at nt 117,769 in strain McKrae,
and the 30 transcript end is assumed to terminate near a polyA
signal ending at nt 125,965. Therefore, the strain McKrae LAT is
predicted to be 8170 nt with a transcription start site at nt
117,796. The LAT promoter is well conserved between strains,
and the little variability that does exist is unlikely to be respon-
sible for increased reactivation in strain McKrae. A previous study
showed that substitution of the McKrae LAT promoter for thenon-spontaneously reactivating KOS strain promoter in a KOS
background did not impart increased reactivation (Strelow et al.,
1994). HSV-1 KOS contains an extended repeat of 15 T residues
beginning at base 118,292 (McKrae) that is not present in other
strains. Downstream of this site is the predicted 50 end of the
McKrae stable LAT intron. The McKrae LAT intron is 2006 bp in
length (genomic coordinates 118,458–120,463) and is 95.9%
conserved between strains. The 50 half of the LAT intron does
not overlap protein coding sequences, whereas the 30 end over-
laps RL2 (ICP0). Major variation within the LAT intron is due to
differences in a repeat element (GCACCCCCACTCCCAC) that varies
in iteration number beginning at nucleotide 119,482 in McKrae
strain (F, H129, and 17 strain: 9 repeats; KOS: 15 repeats;
McKrae: 13 repeats). The 30 end of the LAT transcript is well
conserved between strains likely due to overlapping RL2 (ICP0)
and RL1 (ICP34.5) coding sequence on the opposing strand.
A region of increased sequence variation is present between
the ‘a’ sequence and the 30 end of the LAT transcript (McKrae
coordinates 125,298–125,965). It is the result of tandem repeats
of distinct composition and number. Tandem repeat variation
between strains is found beginning at strain McKrae base
125,520. McKrae repeat elements include twelve iterations of
CCCCAGCCCTCCCCAG and eight iterations of CCCCTCGCCCCC-
TCCCG. The ﬁrst repeat unit is unique from other strains in that
it contains a G–A transition, and strain McKrae contains three
iterations more than any other strain. The McKrae strain second
repeat element is collapsed, missing 188 nucleotides relative to
all other strains, and separated from the upstream repeat by a
100% conserved sequence of 105 bp containing miR-H5.
Micro-RNAs
The role of miRNAs in translation regulation has recently
become of interest in HSV-1 biology. Several miRNAs have been
G. Watson et al. / Virology 433 (2012) 528–537 535discovered in the inverted repeat regions that are capable of
interfering with RS1 (ICP4) and RL2 (ICP0) translation (Umbach
et al., 2008). Deep sequencing was used to identify six miRNAs,
miR-H1 through miR-H6, from the IR region (Umbach et al.,
2008). miR-H1 and miR-H6 are anti-parallel on opposing strands
at McKrae nucleotide 117,312. A KOS-speciﬁc single nucleotide
deletion occurs at base 117,351, affecting only the mature miR-
H1 miRNA. The site giving rise to miR-H1 and H6 is upstream of
the LAT region. miR-H2 and miR-H5 are 100% conserved
between all strains (McKrae nt 120,871). miR-H3, located at
McKrae nucleotide 124,768, contains two sites of H129 strain
speciﬁc variation that fall outside the mature miRNA. miR-H4,
just downstream of miR-H3 at nucleotide 124,916, contains a
6 nucleotide deletion at the 30 end of the proposed miRNA
precursor in strain H129.
The proposed region of miRNA interference in RL2 (ICP0) is
100% conserved between strains, whereas the RS1 (ICP4) tran-
script contains two sites of variation, one of which is speciﬁc to
strain McKrae. Umbach et al. demonstrated that the accumulation
of several point mutations in the RS1 (ICP4) transcript abrogated
translational suppression, and one of these mutations (T–G at bp
126,118) is present in McKrae. If mutations in the miR-H6
recognition site decrease or abolish duplex formation, it seems
logical that de-repression of RS1 (ICP4) translation could facilitate
viral reactivation by allowing transactivation of viral early gene
transcription.
This sequence analysis identiﬁed at least 9 genes and several
non-coding sequences unique for McKrae strain. In addition to
those previously identiﬁed to be associated with pathogenesis
and latency reactivations, such as RL1, RS1, and RL2, three UL
genes (UL36, UL49A, UL56) and three US genes (US7, US10, US11)
were found to be unique for McKrae strain. In addition to gene
variations, non-coding sequences such as LAT, ‘a’ sequence, and
miRNAs, were identiﬁed to contain variations unique for McKrae.
These differences may contribute to observed pathogenic and
reactivation phenotype variability among different strains.Table 3
Oligonucleotide primers for strain McKrae sequence conﬁrmation.
Region Coordinate Forward primer
Gap 116367 AGTTAACGGGCTACGCCTTC
Gap 119377 CACTGTGGTTCTGGCTCCAT
Gap 120557 AGGAAGAGGCAGAGGAGGAA
Gap 125395 CAACACAACTCACAGCGACA
Gap 131169 CTTTTTGCACGGGTAAGCAC
Gap 139181 GAAGGGACTCTGGCGTACAA
Gap 142633 TTTGCACCCAGCCTTTAACT
Gap
Gap 142663 GGGTTCGATTGGCAATGTTGTCTCCCGGTTGATTTTTGGGT
ICP34.5 554 GGTGGGCCCCCGCCTTCTTGTT
ICP4 127397 AACAGCGGGTGGTCCGTGAGC
ICP4 128022 GCATGAGCACCAGCGCGTCG
ICP4 129010 CTCCCCGCTGACGTACCCGT
oriL 61711 CGGTCAAGGGGAGGGTGGGA
UL17 32020 GGGGTCAGGGTTAGAACGTCGTT
UL30 63160 TGTTTTACCGCGTCTACGTC
UL36 71455 GGGTGAAGGGAGGGATTCCCGCGATT
UL37 80910 CCAGGTGCGCCGTGGTTTCGGTGAT
UL43 93821 CGGAAGCCGTTACGCGTGTTACTTT
UL47 101926 GCGTCCCTCCAGAACCTCCACCTT
UL47 100371 GGCGCTTTTTATCGGGAGGAGCTTAT
UL56 115572 GGGGCGCTTACCGCCACAGGAATA
UL6 16504 GCCTGCAAACGTACCTGACAGACAT
US10 143780 CGCTCCATCTTGTGGGGAGAA
US11 143770 CCCGAGCGTACGCTCCATCTTGT
US4 135763 CCCTCGCATGAAGCCCCCAACAT
US7 139132 GGACGCACCAAACGCCAGCCTGTTT
US8 140646 CCCTGTCCGTGGGCGACATAAAMaterials and methods
Virus and cell culture
HSV-1 strain McKrae was propagated in Vero cells maintained
in Eagle Minimal Essential Medium (EMEM) with 2 mM L-gluta-
mine, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate,
10% fetal bovine serum (Promega Scientiﬁc), penicillin (100 U/ml),
and streptomycin (100 mg/ml) (Sigma, St. Louis, MO).
Puriﬁcation of viral DNA
Viral DNA was extracted either from virions puriﬁed as previously
described (Jin et al., 2008) or from puriﬁed intracellular nucleocap-
sids. For nucleocapsid puriﬁcation, infected cells were harvested
when 70–90% of the monolayer showed CPE and processed as
described previously (Scherba et al., 1992). Brieﬂy, ﬂasks were
freeze-thawed twice and pelleted at 5000 rpm at 4 1C for 20 min.
The cell pellet was then washed in PBS and resuspended in 18ml
hypotonic buffer (10 mM Tris–HCl, 10 mM KCl, 5 mM EDTA, pH 8.0)
and 2ml Triton X-100 and incubated on ice for 10 min. The cell debris
was removed by low speed centrifugation at 5000 rpm at 4 1C for
10 min. The viral nucleocapsids were then centrifuged through a 60%
sucrose cushion for virion puriﬁcation. Puriﬁed virions or nucleocap-
sids were digested overnight at 50 1C in 10mM Tris–HCl (pH 8.0),
100 mM EDTA, 1% N-lauroyl sarcosine, and 200 mg/ml proteinase K.
The viral DNA was extracted twice with an equal volume of
phenol:chloroform (1:1) and then precipitated with 2 volumes of
ethanol and 1/10 volume of 3.0 M sodium acetate. The precipitate
was washed once in 70% ethanol and resuspended in TE buffer
(10 mM Tris–HCl, 1 mM EDTA, pH 8.0).
McKrae genome sequencing
Sample preparations for 454 sequencing were carried out
using protocols provided by the manufacturer. The viral genome,Coordinate Reverse primer
119774 TCAGGGGATTTTTGCTGTCT
121176 CCCCATAGTGATCAGCGACT
126001 ACGGCAACGACCTGATTAAG
131670 TCGGTTTCGACCTCAGACTC
139502 GAGGTTGGGGTTTTGGGTCT
143050 GTACGGGGTGGTTTGTTCAT
121334 GGCTCCCGCCAGTCGCGAGCCGCGGCGCCGCGGGGGGCGT
143312 GGCTGTACTCGACCCACTGCCTGCATCTGTTTGGTGCGTT
1182 CGGGTGTAACGTTAGACCGAGTT
127962 GCCGTGAGCCTGGTCGCC
128594 CCATGAGCCGCCGATACGACC
129381 TCCGCATCCTCTTCGTCCTCGT
62267 TTACCGGACCCCCAGGCTCG
33172 GCACGCACGCCTCCGTTGGCGAATA
63640 AGCTCGTTCAGGTGGGATT
72603 GCCGTGTCTGGTGCTCGTGGACAT
81382 CCCCACTATGCAGATGGCCGACAA
94322 GCGACATAACGACCGATCCCGCAAA
102638 CCTTCGCGGGAGATACTGCGTTTTT
100604 GGACGGCAGACCCCGCCTTTCTTCT
116190 GGAACGAGGGGCCGTTTGTCGTTATT
16818 GCGGAGCAGCGTCTGCTGGCTAAT
144137 GCGGCAGGGCAATGTGGAGATT
144258 CGACCCAGATGTTTACTTAAAAGG
136022 GGGACTACGGGACGGTTGGGTTTGT
139603 CGCGGGGATGGCTATCTGGATTAT
140969 GGATGGAGACGTTCGTGCTAAA
G. Watson et al. / Virology 433 (2012) 528–537536total 5 mg of puriﬁed viral DNA, was nebulized to produce
fragments less than 800 bp before sequencing. DNA sequencing
was done using the GS FLXþ System from 454 Life Technology
(Roche). De novo assembly of the McKrae genome was assembled
using 454 Newbler de novo assembler (version 2.5).
PCR DNA sequencing
Primers were designed using the Primer3 software to generate
PCR products spanning genome gaps (Table 3). PCR products were
either gel puriﬁed using the IBI Scientiﬁc Gel/PCR DNA Fragments
Extraction Kit or by ChargeSwitch PCR Clean-Up Kit (Invitrogen)
and sequenced by Sanger Sequencing using standard protocols by
the Center for Genome Research and Biocomputing (CGRB) at
Oregon State University using an ABI Prisms3730 Genetic Analy-
zer with a BigDyes Terminator v. 3.1 Cycle Sequencing Kit and
employing ABI Prisms3730 Data Collection Software v. 3.0 and
ABI Prisms DNA Sequencing Analysis Software v. 5.2. All major
sequence variants in the McKrae draft genome were conﬁrmed by
PCR ampliﬁcation and sequencing as described above. Invitrogen
PCR Enhancer was used as needed in PCR sequencing reactions.
oriL PCR ampliﬁcation
PCR ampliﬁcation with oriL speciﬁc primers was performed as
follows: a 25 ml reaction solution containing 1X Pfx ampliﬁcation
buffer (Invitrogen), 1X or 2X PCR Enhancer solution (Invitrogen),
0.5 mM MgSO4, 0.4 mM dNTP’s, 0.4 mM primers (Forward and
Reverse), 1.0 U of Platinum Pfx DNA polymerase (Invitrogen), and
0.01–0.1 mg of viral DNA, was subjected to 94 1C for 2 min, 30 cycles
of 94 1C for 30 s, 66 1C for 30 s, and 72 1C for 30 s, followed by a
5 min elongation reaction at 72 1C after the ﬁnal cycle.
Comparative sequence analysis
Primary sequence data and PCR sequence data were assembled
using the Geneious software. Annotations of the McKrae genome
and comparative analysis were also done using a Geneious soft-
ware. Protein domain and structure information was gathered
from NCBI and UniProt databases (http://www.ncbi.nlm.nih.gov/;
http://www.ebi.ac.uk/uniprot/).Strain 17: Accession no. X14112
Strain F: Accession no. GU734771
Strain H129: Accession no. GU734772
Strain McKrae: Accession no. JQ730035
Strain HF10: Accession no. DQ889502
Strain KOS: Accession no. JQ780693
Strain KOS: Accession no. JQ673480Acknowledgments
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